Szidonya László, Cserzo Miklós, Hunyady László
Department of Physiology, Semmelweis University, PO Box 259, H-1444 Budapest, Hungary.
J Endocrinol. 2008 Mar;196(3):435-53. doi: 10.1677/JOE-07-0573.
Dimerization or oligomerization of G-protein-coupled receptors (GPCRs) is a novel concept, which may lead to the reevaluation of the actions of pharmacological ligands, hormones, neurotransmitters, and other mediators acting on GPCRs. Although a large number of data obtained using different biophysical, biochemical and structural methods, and functional approaches argue for dimerization or oligomerization of these receptors, several publications criticized the applied methods and challenged the concept. The aim of this paper is to review the data that support the concept of receptor oligomerization, and the most important arguments against it. We conclude that it will require major methodical improvements to obtain decisive proof, whether GPCRs exist in their native membrane environments as homo- or heterodimeric or oligomeric complexes, in which receptor monomers have stable direct interactions. However, overwhelming amounts of data suggest that many GPCRs exhibit functional properties that require direct or indirect interactions between clustered receptors. Although it is difficult to conclude, about the exact nature of these interactions, dimerization or oligomerization of GPCRs is a useful paradigm for pharmacologists to study properties of receptors, which require functionally important clustering of receptors, such as trafficking of newly synthesized receptors to the cell surface, allosteric modulation of ligand binding, signaling specificity, co-internalization, or cross-inhibition of GPCRs.
G蛋白偶联受体(GPCRs)的二聚化或寡聚化是一个新概念,这可能会导致对作用于GPCRs的药理配体、激素、神经递质及其他介质的作用进行重新评估。尽管使用不同的生物物理、生化、结构方法以及功能学方法获得的大量数据支持这些受体的二聚化或寡聚化,但有几篇出版物批评了所应用的方法并对这一概念提出了质疑。本文旨在综述支持受体寡聚化概念的数据以及最重要的反对观点。我们得出结论,要获得决定性证据,即GPCRs在其天然膜环境中是否以同二聚体、异二聚体或寡聚体复合物形式存在,且受体单体之间具有稳定的直接相互作用,还需要重大的方法改进。然而,大量数据表明,许多GPCRs表现出的功能特性需要聚集的受体之间存在直接或间接相互作用。尽管很难确定这些相互作用的确切性质,但GPCRs的二聚化或寡聚化对于药理学家研究受体特性是一个有用的范例,这些特性需要受体进行功能上重要的聚集,如新合成的受体向细胞表面的转运、配体结合的变构调节、信号特异性、共同内化或GPCRs的交叉抑制。